A summary of the current drug interaction guidance from the European Medicines Agency and considerations of future updates.

A summary of the current drug interaction guidance from the European Medicines Agency and considerations of future updates.
Drug Metab Pharmacokinet. 2020 Jan 08;:
Authors: Cole S, Kerwash E, Andersson A
Abstract
The current EMA drug interaction guideline was published in 2012. This guideline gives important recommendations on the information required to elucidate the interaction potential of an investigational drug, both as effects of the investigational drug on the PK of other drugs and effects of other medicinal products on the PK of the investigational drug. Additional information on the use of PBPK modelling to inform drug interaction information, is also available in the guideline on the reporting of physiologically based modelling and simulation (2018). Some points of clarification on the drug interaction guideline, particularly in the area of enzyme induction screening, have been published as the EMA questions and answers (2014) and these points and further additional points, were proposed to be incorporated into a new update of the guideline, for which a concept paper was published in 2017. This update, which is still in progress, was to include new recommendations in line with relevant emerging scientific data (e.g. in the area of drug transporters). It is also intended to harmonise requirements on drug interactions with other Regulatory Agencies and this will be facilitated by the recently announced ICH initiative.
...

Source: Drug Metabolism and Pharmacokinetics - February 1, 2020 Category: Drugs & Pharmacology Tags: Drug Metab Pharmacokinet Source Type: research